Treatment of Anaphylactic Shock
Immediately administer intramuscular epinephrine 0.3-0.5 mg (1:1000 concentration) into the anterolateral thigh as the first-line, life-saving treatment for anaphylactic shock. 1, 2, 3, 4
Immediate First-Line Treatment
Epinephrine Administration (Primary Treatment)
- Administer IM epinephrine 0.3-0.5 mg (1:1000 concentration) for adults or 0.01 mg/kg for children into the anterolateral thigh immediately upon recognition of anaphylaxis 1, 3, 4
- Repeat the dose every 5-15 minutes as needed if symptoms persist or recur 2, 3
- Between 7-18% of patients require more than one dose of epinephrine 1
- Epinephrine is the only medication with life-saving effects across multiple organ systems, preventing and relieving airway obstruction and shock 5
Patient Positioning and Oxygen
- Position the patient supine with legs elevated (unless respiratory distress prevents this position) 3
- Provide supplemental oxygen and monitor oxygen saturation continuously 3
Activate Emergency Response
- Call emergency medical services (EMS) immediately, even if epinephrine is administered 1
- Approximately 500-1000 people die annually in the United States from anaphylaxis, and patients may require advanced interventions including intubation, IV fluids, and vasopressors 1
Advanced Treatment for Severe or Refractory Cases
IV Epinephrine (When IM Fails or Shock is Profound)
- If IV access is already established and the patient has profound hypotension unresponsive to IM epinephrine and IV fluids, administer IV epinephrine 0.05-0.1 mg (1:10,000 concentration) slowly over several minutes 2, 3
- This represents only 5-10% of the cardiac arrest dose to minimize adverse cardiovascular effects 2
- For persistent hypotension, initiate continuous epinephrine infusion at 5-15 μg/min 2, 3
- Continuous hemodynamic monitoring is mandatory when administering IV epinephrine 2
Fluid Resuscitation
- Establish IV access and administer crystalloid bolus: 500-1000 mL for adults or 20 mL/kg for children 3
- Anaphylactic shock can cause up to 37% reduction in circulating blood volume due to vasodilation and increased capillary permeability 6
Persistent Bronchospasm
- If bronchospasm is unresponsive to epinephrine, administer albuterol nebulization 2.5-5 mg in 3 mL saline 3
Adjunctive (Second-Line) Treatments
These medications do NOT substitute for epinephrine and should never delay its administration 7
Antihistamines
- H1 antagonist: Diphenhydramine 25-50 mg IV/IM (1-2 mg/kg for children) 3
- H2 antagonist: Ranitidine 50 mg IV for adults (1 mg/kg for children) 3
Corticosteroids (To Prevent Biphasic Reactions)
- Methylprednisolone 1-2 mg/kg/day IV or prednisone 0.5 mg/kg orally 3
- These provide no acute benefit but may prevent late-phase reactions 3
Special Clinical Situations
Patients on Beta-Blockers
- If the patient is unresponsive to epinephrine and takes beta-blockers, administer glucagon 1-5 mg IV (20-30 μg/kg for children, maximum 1 mg) over 5 minutes, followed by infusion of 5-15 μg/min 2, 3
- Beta-blockade can prevent epinephrine's therapeutic effects 2
Cardiac Arrest from Anaphylaxis
- Perform standard CPR and advanced life support 3
- Administer high-dose epinephrine IV: 1-3 mg (1:10,000) slowly over 3 minutes, followed by 3-5 mg over 3 minutes, then infusion of 4-10 μg/min 3
Refractory Hypotension
- Consider alternative vasopressors such as dopamine (2-20 μg/kg/min) if hypotension persists despite epinephrine 2
- Vasopressin has been reported successful in case reports of severe anaphylactic shock refractory to epinephrine 8
Monitoring and Observation
- Monitor vital signs continuously (blood pressure, heart rate, respiratory rate, oxygen saturation) 3
- Observe for at least 6 hours or until stable and symptoms have resolved 3
- The observation period should be individualized as biphasic reactions are unpredictable and can occur outside typical observation windows 3, 9
Critical Pitfalls to Avoid
- Never delay epinephrine administration while focusing on antihistamines or corticosteroids 2, 7
- Do not confuse epinephrine concentrations: use 1:1000 (1 mg/mL) for IM and 1:10,000 (0.1 mg/mL) for IV 2
- Avoid administering IV epinephrine too rapidly, which increases risk of tachyarrhythmias, hypertension, and potentially lethal arrhythmias 2
- Do not use vasodilators (such as isosorbide) which will worsen the hypotension 6
- Recognize that early intubation may be necessary for airway obstruction—do not delay if edema is progressing 6, 9